Tango Therapeutics Ownership | Who Owns Tango Therapeutics?
Tango Therapeutics Ownership Summary
Tango Therapeutics is owned by 34.68% institutional investors, 2.15% insiders, and 63.17% retail investors. Trv gp iv is the largest institutional shareholder, holding 15.54% of TNGX shares. Fidelity Growth Compy Commingled Pl S is the top mutual fund, with 2.25% of its assets in Tango Therapeutics shares.
TNGX Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Tango Therapeutics | 34.68% | 2.15% | 63.17% |
| Sector | Healthcare Stocks | 57.39% | 9.93% | 32.68% |
| Industry | Biotech Stocks | 68.48% | 9.65% | 21.87% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Trv gp iv | 16.86M | 15.54% | $52.09M |
| Tcg crossover management | 10.74M | 9.89% | $33.17M |
| Ecor1 capital | 10.63M | 9.80% | $32.85M |
| Boxer capital | 8.20M | 7.58% | $70.34M |
| Nextech invest | 5.53M | 5.10% | $17.10M |
| Gilead sciences | 4.85M | 4.47% | $15.00M |
| Blackrock funding, inc. /de | 4.38M | 4.04% | $13.53M |
| Blackrock | 3.99M | 3.69% | $34.22M |
| Farallon capital management | 4.00M | 3.69% | $12.36M |
| Vanguard group | 3.99M | 3.67% | $12.31M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Trv gp iv | 16.86M | 64.97% | $52.09M |
| Mass general brigham | 354.19K | 14.79% | $3.04M |
| Boxer capital | 8.20M | 3.70% | $70.34M |
| Tcg crossover management | 10.74M | 3.24% | $33.17M |
| Nextech invest | 5.53M | 2.77% | $17.10M |
| Superstring capital management lp | 474.95K | 1.27% | $1.47M |
| Ecor1 capital | 10.63M | 1.24% | $32.85M |
| Blue owl capital lp | 1.73M | 1.23% | $5.35M |
| Bain capital life sciences investors | 2.71M | 0.99% | $8.38M |
| Gilead sciences | 4.85M | 0.97% | $15.00M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Tcg crossover management | 10.74M | 3.24% | 10.74M |
| Gilead sciences | 4.85M | 0.97% | 4.85M |
| Farallon capital management | 4.00M | 0.06% | 4.00M |
| Nantahala capital management | 2.80M | 0.37% | 2.80M |
| Blue owl capital lp | 1.73M | 1.23% | 1.73M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Fmr | 8.84K | - | -9.37M |
| Southpoint capital advisors lp | - | - | -5.00M |
| Ecor1 capital | 10.63M | 1.24% | -2.70M |
| Adage capital partners gp | - | - | -2.29M |
| T. rowe price investment management | 3.35M | 0.01% | -1.68M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Tcg crossover management | 10.74M | 3.24% | 10.74M | $33.17M |
| Gilead sciences | 4.85M | 0.97% | 4.85M | $15.00M |
| Farallon capital management | 4.00M | 0.06% | 4.00M | $12.36M |
| Nantahala capital management | 2.80M | 0.37% | 2.80M | $8.67M |
| Blue owl capital lp | 1.73M | 1.23% | 1.73M | $5.35M |
Sold Out
| Holder | Change |
|---|---|
| Farther finance advisors | -5.00 |
| Nelson, van denburg & campbell wealth management group | -12.00 |
| Versant capital management | -28.00 |
| Rothschild investment | -40.00 |
| Nisa investment advisors | -98.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2024 | 71 | -41.80% | 37,625,298 | -62.92% | 34 | 0.40% | 41 | -25.45% | 13 | -63.89% |
| Sep 30, 2024 | 122 | 4.27% | 101,468,815 | 2.91% | 93 | 1.13% | 56 | - | 35 | 9.38% |
| Jun 30, 2024 | 117 | -7.14% | 98,597,035 | 0.20% | 91 | 1.10% | 56 | -3.45% | 32 | -15.79% |
| Mar 31, 2024 | 126 | 5.88% | 98,397,257 | 5.09% | 90 | 0.98% | 58 | -22.67% | 38 | 72.73% |
| Dec 31, 2023 | 119 | 19.00% | 93,633,433 | 5.42% | 96 | 1.15% | 75 | 36.36% | 22 | -15.38% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Fidelity Growth Compy Commingled Pl S | 2.42M | 2.25% | 712.74K |
| Vanguard Total Stock Mkt Idx Inv | 2.20M | 2.04% | - |
| Fidelity Growth Compy Commingled Pl O | 1.69M | 1.58% | - |
| T. Rowe Price Small-Cap Value | 1.66M | 1.54% | - |
| Fidelity Growth Company Fund | 1.53M | 1.43% | 543.72K |
| Fidelity Small Cap Growth | 1.25M | 1.17% | - |
| iShares Russell 2000 ETF | 1.25M | 1.16% | -10.84K |
| T. Rowe Price Small-Cap Stock | 1.19M | 1.11% | 199.50K |
| T. Rowe Price US Small-Cap Core Equity | 1.19M | 1.11% | 277.63K |
| SPDR® S&P Biotech ETF | 1.12M | 1.05% | 16.00K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Feb 04, 2025 | Barry Douglas | General Counsel | Sell | $8.29K |
| Feb 05, 2025 | Barry Douglas | General Counsel | Sell | $8.08K |
| Feb 05, 2025 | Beckman Daniella | Chief Financial Officer | Sell | $12.48K |
| Feb 04, 2025 | Beckman Daniella | Chief Financial Officer | Sell | $12.80K |
| Feb 04, 2025 | Crystal Adam | See Remarks | Sell | $22.21K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q1 | - | 8 |
| 2024 Q4 | 2 | 7 |
| 2024 Q3 | - | 18 |
| 2024 Q2 | - | 7 |
| 2024 Q1 | - | 9 |
TNGX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools